EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats

Bin Xiong, Yaowei Bai, Jiacheng Liu, Tongqiang Li, Yingliang Wang, Chen Zhou

Portal Hypertension & Cirrhosis · 2024-03 · 3 (1) · 1-13

DOI: 10.1002/poh2.75 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portal Hypertension & Cirrhosis, online erschienen am 03.03.2024. Verfasst von Bin Xiong und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Neovascularization plays a crucial role in liver fibrosis (LF), and blocking vascular endothelial growth factor receptors (VEGFR) has been shown to improve fibrosis. The aim of our study was to investigate the role of dual neovascularization targets, VEGFR, and platelet‐derived growth factor receptor (PDGFR), in ameliorating fibrosis.

Methods

In vitro, we observed the effects of apatinib (APA) (a VEGFR inhibitor) and donafenib (DON) (a VEGFR and PDGFR inhibitor) on the activation, proliferation, and apoptosis of hepatic stellate cells (HSCs) from rats and humans. In vivo, we established a thioacetamide (TAA)‐induced liver fibrosis rat model to explore the antifibrosis effect of APA and DON. We used the method of random table to randomly divide the rats into 4 groups. We detected the expression of angiogenesis‐related proteins using Western blot and immunohistochemistry.

Results

APA and DON inhibited the proliferation and activation of HSCs, promoted apoptosis of HSCs, and arrested the S phase of the cell cycle in vitro. We also found that DON had a stronger inhibitory effect on HSCs. In vivo, APA and DON ameliorated liver fibrosis, reduced collagen deposition and α‐SMA expression in rats, and DON had a stronger improvement effect. APA and DON downregulated the expression of VEGFR2 while inhibiting the phosphorylation of Akt and ERK1/2. DON can act through both VEGF and PDGF pathways, whereas APA can only act through the VEGF pathway.

Conclusion

Antiangiogenesis is a promising approach for the treatment of fibrosis. Compared with a single‐target drug (APA), the dual‐target drug (DON) can achieve better therapeutic effects.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiong, B., Bai, Y., Liu, J., Li, T., Wang, Y., & Zhou, C. (2024). Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats. Portal Hypertension & Cirrhosis, 3(1), 1-13. https://doi.org/10.1002/poh2.75

Vancouver

Xiong B, Bai Y, Liu J, Li T, Wang Y, Zhou C. Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats. Portal Hypertension & Cirrhosis. 2024;3(1):1-13. doi:10.1002/poh2.75

BibTeX
@article{Xiong2024,
  author = {Xiong, Bin and Bai, Yaowei and Liu, Jiacheng and Li, Tongqiang and Wang, Yingliang and Zhou, Chen},
  title = {Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats},
  journal = {Portal Hypertension & Cirrhosis},
  year = {2024},
  volume = {3},
  number = {1},
  pages = {1--13},
  doi = {10.1002/poh2.75}
}
Kostenlos starten →